Inventor · disambiguated record
Yoshihiro Ishihara
Also filed as: ISHIHARA YOSHIHIRO
2 granted patents·16 pending applications·11 citations·filing 2019–2024
56Inventor score
Files withVERTEX PHARMA18
Top patents by PatentIndex Score
18 records- 0195US12421251B2Cystic fibrosis transmembrane conductance regulator modulating agentsVERTEX PHARMA·Filed 2020·Granted Sep 23, 2025·5 cites·25 claims
- 0293US11414439B2Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2019·Granted Aug 16, 2022·6 cites·31 claims
- 0385US2025171469A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 0476US2023312616A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 0567US2021139514A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2019·Application pending·0 cites
- 0661US2025122218A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 0760US2025388541A1Heteroaryl compounds for the treatment of painVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 0856US2023382924A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 0956US2023416275A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 1056US2023373974A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 1156US2023382925A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 1256US2023373939A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 1356US2023373935A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 1456US2023365587A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 1556US2024018161A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 1656US2023374038A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 1756US2024150377A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 1850US2022313698A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yoshihiro Ishihara files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →